Home LiteratureArticle Details
PMID: 2813376 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S.

Abnormal processing of multiple proteins in Alzheimer disease.

Zhang H, Sternberger NH, Rubinstein LJ, Herman MM, Binder LI, Sternberger LA

Abstract

Cerebrovascular amyloid is the main constituent of the perivascular and neuritic plaques typical of Alzheimer disease, whereas neurofilaments and microtubule-associated tau protein have been considered primary contributors to the formation of the characteristic Alzheimer tangles. Plaques and tangles and their constituents have at times been ascribed a role in pathogenesis of the disease. Normally, neurofilaments become phosphorylated only upon axonal entry. In many neurologic disorders, neurofilament phosphorylation, as detected by any of the available monoclonal antibodies (mAbs) to neurofilament phosphorylated epitopes is shifted from an axonal to a cell-body location. An exception is provided by Alzheimer disease, where tangles (which are neuronal cell-body-derived structures) exhibit only one phosphorylated epitope. However, the very presence of neurofilaments in tangles and plaques has been questioned because of a reported cross-reaction of mAbs to phosphorylated neurofilaments with tau protein. On reinvestigating this cross-reactivity we found that four of five mAbs to phosphorylated neurofilaments and four of five mAbs to nonphosphorylated neurofilaments failed to react with tau protein. A fifth mAb (07-5) to phosphorylated neurofilament cross-reacted with partially denatured tau protein at an affinity 1/1700th of that for denatured neurofilaments; nondenatured tau protein in tissue sections did not cross-react. A fifth mAb (02-40) to nonphosphorylated neurofilament also cross-reacted weakly. In Alzheimer disease normal-appearing axons were revealed with all the mAbs to phosphorylated neurofilaments, but tangles were revealed with only one of them (mAb 07-5). mAb to tau protein did not stain or did so indistinctly. Four of five mAbs to nonphosphorylated neurofilaments failed to reveal axons. Upon dephosphorylation of tissue, staining by mAbs to phosphorylated neurofilaments disappeared, and axons were revealed with the mAb to tau protein and all mAbs to the nonphosphorylated neurofilaments. Tangles became stained with tau mAb and one mAb to the nonphosphorylated neurofilaments (mAb 10-1). Quantitative evaluation of immunocytochemical staining intensities and immunoblot cross-reactivity showed that neurofilaments are, indeed, constituents of tangles--apparently exceeding the concentration of tau protein 17-fold. Contribution of both conformation and primary structure to IgG specificity may explain the lack of any cross-reaction of mAbs to neurofilaments with tau protein in intact tissue and the appearance of cross-reaction in immunoblots where conformation specificity may be largely lost. The present data extend earlier findings of abnormal processing of neurofilaments and tau protein in Alzheimer disease and, together with reported abnormal processing of cerebrovascular amyloid beta-protein, suggest that inhibition of the processing of multiple proteins is basic to the pathogenesis of Alzheimer disease, whereas formation of plaques and tangles could be merely the most striking histologic result.

MeSH Terms
Adult Aged Aged, 80 and over Aging Alzheimer Disease/metabolism,pathology Brain/growth & development,metabolism,pathology Humans Nerve Tissue Proteins/analysis,genetics Phosphorylation Protein Processing, Post-Translational Reference Values
Chemicals
Nerve Tissue Proteins
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Zhang H
Department of Neurology, University of Maryland School of Medicine, Baltimore 21201.
Sternberger N H
Rubinstein L J
Herman M M
Binder L I
Sternberger L A
References (22)
22 references, click to expand
  1. Immunohistochemical evidence for the derivation of a peptide ligand from the amyloid beta-protein precursor of Alzheimer disease.
    Proc Natl Acad Sci U S A. 1988 Apr;85(8):2790-4 PMID: 3282239
  2. Alzheimer's disease: its proteins and genes.
    Cell. 1988 Feb 12;52(3):307-8 PMID: 2964275
  3. Amino acid substitution and the antigenicity of globular proteins.
    Adv Immunol. 1975;20:71-123 PMID: 47221
  4. Effects of primary antiserum dilution on staining of "antigenrich" tissues with the peroxidase antiperoxidase technique.
    J Histochem Cytochem. 1977 Jun;25(6):443-7 PMID: 69655
  5. A critical review of immunocytochemical methods for light microscopy.
    J Neurosci Methods. 1979 Mar;1(1):3-23 PMID: 94643
  6. IgG antibodies to phosphorylcholine exhibit more diversity than their IgM counterparts.
    Nature. 1981 May 7;291(5810):29-34 PMID: 7231520
  7. Immunocytochemistry of brain-reactive monoclonal antibodies in peripheral tissues.
    Cell Tissue Res. 1983;228(3):459-73 PMID: 6187465
  8. Monoclonal antibodies distinguish phosphorylated and nonphosphorylated forms of neurofilaments in situ.
    Proc Natl Acad Sci U S A. 1983 Oct;80(19):6126-30 PMID: 6577472
  9. Hemagglutinin of swine influenza virus: a single amino acid change pleiotropically affects viral antigenicity and replication.
    Proc Natl Acad Sci U S A. 1983 Nov;80(22):6996-7000 PMID: 6580621
  10. The purification of tau protein and the occurrence of two phosphorylation states of tau in brain.
    J Biol Chem. 1984 Oct 10;259(19):12241-5 PMID: 6090460
  11. Alzheimer's disease: immunoreactivity of neurofibrillary tangles with anti-neurofilament and anti-paired helical filament antibodies.
    Brain Res. 1984 Sep 24;310(2):249-60 PMID: 6207891
  12. Paired helical filaments from Alzheimer disease patients contain cytoskeletal components.
    Proc Natl Acad Sci U S A. 1985 Jun;82(11):3916-20 PMID: 3889918
  13. Aberrant neurofilament phosphorylation in Alzheimer disease.
    Proc Natl Acad Sci U S A. 1985 Jun;82(12):4274-6 PMID: 3159022
  14. The distribution of tau in the mammalian central nervous system.
    J Cell Biol. 1985 Oct;101(4):1371-8 PMID: 3930508
  15. Phosphorylated neurofilament antigens in neurofibrillary tangles in Alzheimer's disease.
    J Neuropathol Exp Neurol. 1986 Jan;45(1):56-64 PMID: 3510274
  16. The unlabeled antibody method: comparison of peroxidase-antiperoxidase with avidin-biotin complex by a new method of quantification.
    J Histochem Cytochem. 1986 May;34(5):599-605 PMID: 3517144
  17. Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology.
    Proc Natl Acad Sci U S A. 1986 Jul;83(13):4913-7 PMID: 3088567
  18. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor.
    Nature. 1987 Feb 19-25;325(6106):733-6 PMID: 2881207
  19. Recognition of tau epitopes by anti-neurofilament antibodies that bind to Alzheimer neurofibrillary tangles.
    Proc Natl Acad Sci U S A. 1987 May;84(10):3410-4 PMID: 2437579
  20. Recognition of Alzheimer paired helical filaments by monoclonal neurofilament antibodies is due to crossreaction with tau protein.
    Proc Natl Acad Sci U S A. 1987 May;84(10):3415-9 PMID: 3106969
  21. Ubiquitin is detected in neurofibrillary tangles and senile plaque neurites of Alzheimer disease brains.
    Proc Natl Acad Sci U S A. 1987 May;84(9):3033-6 PMID: 3033674
  22. Neurofilamentous abnormalities in motor neurons in spontaneously occurring animal disorders.
    J Neuropathol Exp Neurol. 1988 Jul;47(4):420-31 PMID: 2455022
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
1989-10-00
Pages
8045-9
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC298211
Subset
IM
Grants
NINDS NIH HHS · NS 24185 · United States
NINDS NIH HHS · NS 24423 · United States
NINDS NIH HHS · NS 26583 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]